Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-07

FDA Approved: ATOVAQUONE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)

View source ↗

Summary

FDA approved a supplemental application for atovaquone submitted by Chartwell Governmental & Specialty RX, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atovaquone (Atovaquone)

Snippet

SUPPL AP for ATOVAQUONE (ATOVAQUONE)